Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06699537 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lacticaseibacillus Rhamnosus LRa05 for Alleviating Allergic Rhinitis in Children

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2024 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The clinical trial aims to investigate the efficacy of Lactobacillus rhamnosus LRa05 in alleviating allergic rhinitis and its impact on the gut microbiota among 70 pediatric participants aged 4-12. The primary objective is to validate the improvement in allergic rhinitis symptoms following an 8-week intervention with Lactobacillus rhamnosus LRa05. Participants were instructed to consume the probiotic powder daily for approximately 8 weeks. At baseline, week 4, and week 8 endpoints, assessments of nasal symptoms, quality of life questionnaires, and stool samples for microbiota analysis were conducted on the participants, and blood samples were collected for immune-related factor testing.
Trial Details
NCT Number NCT06699537
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions
(from sponsor)		 Allergic Rhinitis (AR)
Related terms Rhinitis, Allergic
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov